title: Rationale for a nanomedicine approach to thrombolytic therapy.
authors.affiliation: Department of Medicine, Division of Cardiology, 4320 Forest Park Ave, Suite 101, St Louis, MO 63108, USA. greg@cvu.wustl.edu
authors.forename: Gregory M
authors.initials: GM
authors.lastname: Lanza
authors.forename: Jon N
authors.initials: JN
authors.lastname: Marsh
authors.forename: Grace
authors.initials: G
authors.lastname: Hu
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Scott
authors.forename: Anne H
authors.initials: AH
authors.lastname: Schmieder
authors.forename: Shelton D
authors.initials: SD
authors.lastname: Caruthers
authors.forename: Dipanjan
authors.initials: D
authors.lastname: Pan
authors.forename: Samuel A
authors.initials: SA
authors.lastname: Wickline
mesh_terms: D002545:Brain Ischemia / Q000628:therapy*; D006801:Humans; D050997:Nanomedicine; D020521:Stroke / Q000628:therapy*; D015912:Thrombolytic Therapy / Q000379:methods*